Search results for “Pomalidomide” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 272 patents, we discovered top 76 key players by total patent application. Celgene Corp., Teva Pharmaceuticals Australia Pty Ltd, Bristol Myers Squibb Co. are dominant in this area. They take 36.03% of the total patent filing.
Celgene Corp.
New Jersey, United States
Patent: 63
Teva Pharmaceuticals Australia Pty Ltd
United States
Patent: 19
Bristol Myers Squibb Co.
New York, United States
Patent: 16
Sanofi SA
France
Patent: 10
Mylan Laboratories Ltd.
Telangana, India
Patent: 10
MorphoSys AG
Bayern, Germany
Patent: 8
Deuteria Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
Nanjing Noratech Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 7
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 6
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 107 patents applied in the last 5 years. We discover 59 most active companies in this area. The fast-growing Sanofi SA, Glaxosmithkline Intellectual Property Development Ltd., Nanjing Noratech Pharmaceutical Co. Ltd. take 19.63% of patent filing during this period.
Sanofi SA
France
Patent: 10
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Nanjing Noratech Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 5
Bristol Myers Squibb Co.
New York, United States
Patent: 5
Janssen Biotech
Belgium
Patent: 4
Tecnimede Sociedade Tecnico Medicinal SA
Portugal
Patent: 4
Julius-Maximilians-Universität Würzburg
Bayern, Germany
Patent: 4
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 4
Sanofi-Aventis U.S. LLC
New Jersey, United States
Patent: 3
Henan Gulf Stream Biotechnology Co., Ltd.
Henan Sheng, China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 107 patents in last 5 years, we discover 51 new entrants. Sanofi SA, Glaxosmithkline Intellectual Property Development Ltd., Janssen Biotech are the most active new entrants in this area.
Sanofi SA
France
Patent: 10
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Janssen Biotech
Belgium
Patent: 4
Tecnimede Sociedade Tecnico Medicinal SA
Portugal
Patent: 4
Julius-Maximilians-Universität Würzburg
Bayern, Germany
Patent: 4
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 4
Sanofi-Aventis U.S. LLC
New Jersey, United States
Patent: 3
Henan Gulf Stream Biotechnology Co., Ltd.
Henan Sheng, China
Patent: 3
Midas Pharma GmbH
Rheinland-Pfalz, Germany
Patent: 2
Renhe Xidelong Pharmaceutical Co., Ltd.
Henan Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 36 patents, we discovered top 23 universities and scientific research institutions by total patent application. Shanghai Institute of Pharmaceutical Industry, Julius-Maximilians-Universität Würzburg, China Pharmaceutical University are dominant in this area. They take 38.89% of the total patent filing.
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 5
Julius-Maximilians-Universität Würzburg
Bayern, Germany
Patent: 4
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2
The Johns Hopkins University
United States
Patent: 1
Shandong University
Shandong Sheng, China
Patent: 1
California Institute of Technology
California, United States
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Sichuan University
Sichuan Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: